New program aims to keep at-risk youth on track
NCT ID NCT05114733
First seen Jan 23, 2026 · Last updated Apr 29, 2026 · Updated 10 times
Summary
This study tested a program called InVEST that provides personalized support to help teens and young adults (ages 12-22) who are at high risk for psychosis improve their functioning in school or work. The study enrolled 26 participants and measured how feasible and acceptable the program was, as well as its early effects on role functioning. The goal was to gather information to refine the program and plan larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL HIGH RISK FOR PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center/ Massachusetts Mental Health Center
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.